Company Filing History:
Years Active: 2009
Title: The Innovations of Kin Chlu Fong
Introduction
Kin Chlu Fong is an accomplished inventor based in Longmont, Colorado. He has made significant contributions to the field of pharmaceuticals, particularly in the development of selective estrogen receptor modulators. His work is aimed at addressing critical health issues such as endometriosis and uterine leiomyoma.
Latest Patents
Fong holds a patent for "Selective estrogen receptor modulators containing a phenylsulfonyl group." This invention relates to a selective estrogen receptor modulator of formula I or a pharmaceutical acid addition salt thereof. It is particularly useful for treating conditions like endometriosis and uterine leiomyoma/leiomyomata.
Career Highlights
Fong is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. His role involves research and development in innovative treatments that can improve patient outcomes. With one patent to his name, he has already made a mark in the industry.
Collaborations
Fong has collaborated with notable colleagues, including Robert Dean Dally and Jeffrey A. Dodge. These partnerships have likely contributed to the advancement of his research and the successful development of his patent.
Conclusion
Kin Chlu Fong is a notable inventor whose work in selective estrogen receptor modulators has the potential to impact the treatment of significant health conditions. His contributions to Eli Lilly and Company and the pharmaceutical field highlight the importance of innovation in healthcare.